WORK Medical Technology Group
3 hedge funds and large institutions have $21K invested in WORK Medical Technology Group in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
8,527% more capital invested
Capital invested by funds: $244 → $21K (+$20.8K)
200% more funds holding
Funds holding: 1 → 3 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$855K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32.8K |
| 3 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$8.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIAM
Caitong International Asset Management
Hong Kong
|
-$4 |
WOK Hedge Fund Activity: Q2 2026 in Review
3 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in WORK Medical Technology Group (WOK) for Q2 2026, worth a combined $21K — up 8,527% from $244 a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new WOK positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $855K. The largest seller was Caitong International Asset Management, cutting an estimated $4.
- 3 institutional investors held WORK Medical Technology Group (WOK) as of Q2 2026, up from 1 in Q1 2026.
- Funds reported $21K of WORK Medical Technology Group stock for Q2 2026, up 8,527% quarter-over-quarter.
- 2 funds opened new WORK Medical Technology Group positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest WORK Medical Technology Group buyer in Q2 2026 was UBS Group, an estimated $855K added.
- The largest WORK Medical Technology Group seller in Q2 2026 was Caitong International Asset Management, an estimated $4 sold.
Based on aggregated 13F filings for Q2 2026.